Everyone involved with OneMore shares our passion to bring new advances to pancreatic cancer patients as rapidly as possible; providing the only coordinated effort in the world dedicated to rapidly translating research discoveries into new treatments and supportive care for patients with pancreatic cancer.

The OneMore alliance is focused on an all out effort to identify the genes that may reveal one's predisposition to getting the disease and understanding the genetic changes contributing to its development and resistance to therapy. Experiments that were impossible and impractical only a few years ago are now conducted every day, leading us to earlier diagnoses and smarter treatments. 

In addition, we continue to develop novel therapies for the cure of pancreatic cancer, design relevant clinical trials and help launch fundraising programs to support these activities.

 Through our international partnerships with academic, clinical, and corporate entities, it is our mission to deliver all relevant discoveries to the patient bedside in the form of improved healthcare interventions more rapidly than ever.